Pharmacist from Estácio/FIR (2018), Master in Cellular and Molecular Biology from FMRP/USP (2020), and Ph.D. in Pathogen-Host Relationship Biology from ICB/USP (2025), with expertise in Glycobiology, Immunology, and Parasitology. Currently, I work as a Medical-Scientific Project Analyst at Cristália Produtos Químicos Farmacêuticos, contributing to the prospection and evaluation of new drugs, the review of scientific and technical materials, and the development of strategic insights for decision-making. With strong experience in market analysis and prescription trends, I support the monitoring of the competitive landscape to guide medical and business strategies. Additionally, I take part in the presentation of scientific-medical topics and provide technical support to multidisciplinary teams, collaborating on innovation and portfolio management in the pharmaceutical industry. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Trypanosoma cruzi is the etiologic agent of Chagas disease, also known as American trypanosomiasis, a potentially fatal parasitic infection that affects between 6 and 8 million individuals worldwide. Although Chagas disease is mainly found in endemic regions of Latin American countries, this infection is recognized as a potentially serious emerging global health problem. During infection …
The ArtinM lectin, obtained from the saline extract of Artocarpus heterophyllus seed, recognizes Man± 1-3 (Man± 1-6) Man in N-glycans core. This mechanism is used by ArtinM to induce the activation of neutrophils and macrophages by TLR2/CD14 recognition, and T cell activation through CD3 interaction. The immunomodulatory activity of ArtinM on these cells demonstrates a protective effect a…
| 2 / 2 | Completed scholarships in Brazil |
| Associated processes | |
CV Lattes
ORCID